Bolt Biotherapeutics Earnings Estimate
| BOLT Stock | USD 5.64 0.00 0.00% |
Bolt Biotherapeutics Revenue Breakdown by Earning Segment
By analyzing Bolt Biotherapeutics' earnings estimates, investors can diagnose different trends across Bolt Biotherapeutics' analyst sentiment over time as well as compare current estimates against different timeframes. At this time, Bolt Biotherapeutics' Gross Profit is comparatively stable compared to the past year. Gross Profit Margin is likely to gain to 0.75 in 2025, whereas Pretax Profit Margin is likely to drop (8.62) in 2025. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bolt Biotherapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
Bolt Biotherapeutics Earnings per Share Projection vs Actual
About Bolt Biotherapeutics Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Bolt Biotherapeutics earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Bolt Biotherapeutics estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Bolt Biotherapeutics fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.| Last Reported | Projected for Next Year | ||
| Retained Earnings | -427.4 M | -406 M | |
| Earnings Yield | (3.09) | (2.93) | |
| Price Earnings Ratio | (0.32) | (0.34) | |
| Price Earnings To Growth Ratio | 0.03 | 0.03 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Bolt Stock Analysis
When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.